{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T08:21:20Z","timestamp":1793521280682,"version":"4.5.0"},"reference-count":60,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2022,10,5]],"date-time":"2022-10-05T00:00:00Z","timestamp":1664928000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Endocrinol."],"abstract":"<jats:sec>\n                    <jats:title>Aim<\/jats:title>\n                    <jats:p>Diabetic retinopathy (DR) is widely considered the earliest and most common microvascular complication of diabetes. However, recent studies have shown that retinal nerve fiber layer and corneal nerve abnormalities may be present in diabetic patients without retinopathy. This preliminary study aimed to establish if structural and functional changes in the nerve fiber layer of the retina and cornea occur in patients with type 1 diabetes (T1DM) without retinopathy.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Twenty patients with T1DM, without clinical evidence of retinopathy (Age: 47.0 \u00b1 2.5 years; Duration diabetes: 27.0 \u00b1 3 years) and 15 age-matched healthy control subjects underwent detailed medical neurological examinations. Ophthalmic examinations using Spectral Domain Optical coherence tomography (SD-OCT), Standard Automated Perimetry (SAP), Flicker Defined Form High Edge Perimetry (FDF), Corneal Confocal Microscopy (CCM) and Non-contact corneal Aesthesiometry (NCCA) were performed to quantify the structure and function of the nerves in the retina and cornea, respectively.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>At the structural level, retinal nerve fiber layer thickness (RNFL) was significantly reduced in the superior nasal (p=0.001) and inferior temporal (p=0.004) sectors, in diabetic patients. Retinal ganglion layer function was reduced in the patient group when assessed using Flicker Defined Form Perimetry (FDF), but this was not significant. The function of the cornea assessed by corneal sensitivity, using a non-contact corneal aesthesiometer (NCCA), was significantly reduced (p=0.001). Structural assessment of corneal nerves using corneal confocal microscopy (CCM) showed reduction at corneal nerve fiber density (CNFD) (p=0.01), branch density (CNBD) (p=0.006) and length (CNFL) (p=0.01) in patients with diabetes. Compared to control subjects, the percentage of abnormality in patients with T1DM for RNFL was 32% while the FDF was abnormal in 61% of patients. Corneal abnormality was observed in 47% for NCCA, 28% for CNFD, and 17% for CNFL. There was no correlation between neuronal damage in the retina and cornea.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Neuronal abnormalities were observed in both the retina and cornea of diabetic patients without evidence of retinopathy. The prevalence of structural and functional changes was higher in the retina compared to the cornea. This preliminary study suggests that structural neuronal changes may occur in parallel and correlate with functional changes. The assessment of corneal and retinal nerve structure may be clinically useful for detecting and monitoring the earliest stages of diabetic microvascular abnormalities.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fendo.2022.790255","type":"journal-article","created":{"date-parts":[[2022,10,5]],"date-time":"2022-10-05T04:30:15Z","timestamp":1664944215000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":16,"title":["Neurodegeneration of the cornea and retina in patients with type 1 diabetes without clinical evidence of diabetic retinopathy"],"prefix":"10.3389","volume":"13","author":[{"given":"Josie","family":"Carmichael","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hassan","family":"Fadavi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mitra","family":"Tavakoli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2022,10,5]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/s0168-8227(99)00055-8","article-title":"The temporal development of retinopathy and nephropathy in type 1 diabetes mellitus during 15 years diabetes duration","volume":"45","author":"L\u00f6vestam-Adrian","year":"1999","journal-title":"Diabetes Res Clin Pract"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1136\/bjophthalmol-2016-310063","article-title":"Differences in incidence of diabetic retinopathy between type 1 and 2 diabetes mellitus: A nine-year follow-up study","volume":"101","author":"Romero-Aroca","year":"2017","journal-title":"Br J Ophthalmol"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1007\/s00125-018-4692-1","article-title":"Neurodegeneration in diabetic retinopathy: does it really matter","volume":"61","author":"Sim\u00f3","year":"2018","journal-title":"Diabetologia"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.2337\/db13-1628","article-title":"Progression of early retinal dysfunction in diabetes over time: Results of a long-term prospective clinical study","volume":"63","author":"Hellgren","year":"2014","journal-title":"Diabetes"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1016\/j.visres.2017.03.003","article-title":"Diabetic retinopathy is a neurodegenerative disorder","volume":"139","author":"Lynch","year":"2017","journal-title":"Vision Res"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1111\/j.1444-0938.2012.00733.x","article-title":"Retinal neuropathy precedes vasculopathy in diabetes: A function-based opportunity for early treatment intervention","volume":"95","author":"Adams","year":"2012","journal-title":"Clin Exp Optometry"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.2337\/db13-1673","article-title":"Neuroretinal dysfunction with intact blood-retinal barrier and absent vasculopathy in type 1 diabetes","volume":"63","author":"Reis","year":"2014","journal-title":"Diabetes"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1007\/s00125-012-2457-9","article-title":"Visual sensitivity loss in the central 30\u00b0 of visual field is associated with diabetic peripheral neuropathy","volume":"4","author":"Sampson","year":"2012","journal-title":"Diabetologia"},{"key":"B9","doi-asserted-by":"publisher","first-page":"1412","DOI":"10.1167\/iovs.17-21873","article-title":"Assessment of inner retinal layers and choroidal thickness in type 1 diabetes mellitus: A cross-sectional study","volume":"8","author":"Carbonell","year":"2019","journal-title":"J Clin Med"},{"key":"B10","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s00417-016-3548-y","article-title":"The neurovascular unit and the pathophysiologic basis of diabetic retinopathy","volume":"255","author":"Gardner","year":"2017","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"B11","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/j.tem.2013.09.005","article-title":"Neurodegeneration in the diabetic eye: New insights and therapeutic perspectives","volume":"25","author":"Simo","year":"2014","journal-title":"Trends Endocrinol Metab"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1016\/j.visres.2010.08.024","article-title":"Association of visual function and ganglion cell layer thickness in patients with diabetes mellitus type 1 and no or minimal diabetic retinopathy","volume":"51","author":"Van Dijk","year":"2011","journal-title":"Vision Res"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.2337\/dc16-2641","article-title":"Diabetic retinopathy: A position statement by the American diabetes association","volume":"40","author":"Solomon","year":"2017","journal-title":"Diabetes Care"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1167\/iovs.17-21873","article-title":"Approach for a clinically useful comprehensive classification of vascular and neural aspects of diabetic retinal disease","volume":"59","author":"Abramoff","year":"2018","journal-title":"Invest Ophthalmol Visual Sci"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1007\/s00125-018-4653-8","article-title":"Corneal confocal microscopy for identification of diabetic sensorimotor polyneuropathy: A pooled multinational consortium study","volume":"61","author":"Perkins","year":"2018","journal-title":"Diabetologia"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.2337\/dc14-2311","article-title":"Normative values for corneal nerve morphology assessed using corneal confocal microscopy: A multinational normative data set","volume":"38","author":"Tavakoli","year":"2015","journal-title":"Diabetes Care"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2021.671257","article-title":"Advances in screening, early diagnosis and accurate staging of diabetic neuropathy","volume":"12","author":"Carmichael","year":"2021","journal-title":"Front Endocrinol"},{"key":"B18","doi-asserted-by":"publisher","first-page":"898","DOI":"10.3109\/02713683.2012.683507","article-title":"Correlation of diabetic retinopathy and corneal neuropathy using confocal microscopy","volume":"37","author":"Nitoda","year":"2012","journal-title":"Curr Eye Res"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0052157","article-title":"Imaging and quantification of subbasal nerve plexus in healthy volunteers and diabetic patients with or without retinopathy","volume":"8","author":"Zhivov","year":"2013","journal-title":"PloS One"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1111\/dme.12324","article-title":"Corneal nerve fibre damage precedes diabetic retinopathy in patients with type 2 diabetes mellitus","volume":"31","author":"Bitirgen","year":"2013","journal-title":"Diabetic Med J Br Diabetic Assoc"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0123517","article-title":"Corneal confocal microscopy detects neuropathy in patients with type 1 diabetes without retinopathy or microalbuminuria","volume":"10","author":"Petropoulos","year":"2015","journal-title":"PloS One"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.2337\/diacare.22.9.1479","article-title":"Risk factors for severity of diabetic polyneuropathy: Intensive longitudinal assessment of the Rochester diabetic neuropathy study cohort","volume":"22","author":"Dyck","year":"1999","journal-title":"Diabetes Care"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.2337\/diab.41.4.430","article-title":"Risk of early-onset proliferative retinopathy in IDDM is closely related to cardiovascular autonomic neuropathy","volume":"41","author":"Krolewski","year":"1992","journal-title":"Diabetes"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1007\/s00125-020-05195-4","article-title":"Diabetic retinopathy: looking beyond the eyes","volume":"63","author":"Sim\u00f3","year":"2020","journal-title":"Diabetologia"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1522014113","article-title":"Retinal neurodegeneration may precede microvascular changes characteristic of diabetic retinopathy in diabetes mellitus","volume":"113","author":"Sohn","year":"2016","journal-title":"Proc Natl Acad Sci USA"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1007\/s00125-018-4692-1","article-title":"Early treatment diabetic retinopathy study design and baseline patient characteristics. ETDRS report number 7","volume":"98","year":"1991","journal-title":"Ophthalmology"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1167\/iovs.12-10892","article-title":"Structure-function relationship between FDF, FDT, SAP, And scanning laser ophthalmoscopy in glaucoma patients","volume":"53","author":"Lamparter","year":"2012","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.3791\/2194","article-title":"Corneal confocal microscopy: a novel non-invasive technique to quantify small fibre pathology in peripheral neuropathies","volume":"2194","author":"Tavakoli","year":"2011","journal-title":"J Vis Exp"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.2337\/dc07-0175","article-title":"Corneal sensitivity is reduced and relates to the severity of neuropathy in patients with diabetes","volume":"30","author":"Tavakoli","year":"2007","journal-title":"Diabetes Care"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1212\/wnl.36.10.1300","article-title":"Neuropathy symptom profile in health, motor neuron disease, diabetic neuropathy, and amyloidosis","volume":"36","author":"Dyck","year":"1986","journal-title":"Neurology"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1007\/BF00400697","article-title":"A multicentre study of the prevalence of diabetic peripheral neuropathy in the united kingdom hospital clinic population","volume":"36","author":"Young","year":"1993","journal-title":"Diabetologia"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.2337\/dc13-2005","article-title":"Does the prevailing hypothesis that small-fiber dysfunction precedes large-fiber dysfunction apply to type 1 diabetic patients","volume":"37","author":"Breiner","year":"2014","journal-title":"Diabetes Care"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1016\/j.jdiacomp.2006.03.001","article-title":"Diabetic microvascular complications\u2013can the presence of one predict the development of another","volume":"20","author":"Girach","year":"2006","journal-title":"J Diabetes Complications"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1167\/iovs.10-6293","article-title":"The significance of vascular and neural apoptosis to the pathology of diabetic retinopathy","volume":"52","author":"Barber","year":"2011","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"B35","doi-asserted-by":"publisher","first-page":"57","DOI":"10.4239\/wjd.v1.i2.57","article-title":"Neurodegeneration: An early event of diabetic retinopathy","volume":"1","author":"Villarroel","year":"2010","journal-title":"World J Diabetes"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.1167\/iovs.12-11309","article-title":"Retinal neurodegeneration in type II diabetic otsuka long-Evans tokushima fatty rats","volume":"54","author":"Yang","year":"2013","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.1172\/JCI2425","article-title":"Neural apoptosis in the retina during experimental and human diabetes. early onset and effect of insulin","volume":"102","author":"Barber","year":"1998","journal-title":"J Clin Invest"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.1097\/ICU.0b013e32835f8bf8","article-title":"Optical coherence tomography\u2013current and future applications","volume":"24","author":"Adhi","year":"2013","journal-title":"Curr Opin Ophthalmol"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.1136\/bjo.2010.191841","article-title":"Early diabetic changes in the nerve fibre layer at the macula detected by spectral domain optical coherence tomography","volume":"95","author":"Park","year":"2011","journal-title":"Br J Ophthalmol"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.1159\/000333220","article-title":"Does neuronal damage precede vascular damage in subjects with type 2 diabetes mellitus and having no clinical diabetic retinopathy","volume":"47","author":"Verma","year":"2012","journal-title":"Ophthalmic Res"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.1038\/eye.2009.184","article-title":"Is neuronal dysfunction an early sign of diabetic retinopathy? microperimetry and spectral domain optical coherence tomography (SD-OCT) study in individuals with diabetes, but no diabetic retinopathy","volume":"23","author":"Verma","year":"2009","journal-title":"Eye (Lond)"},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.1167\/iovs.11-8997","article-title":"Early neurodegeneration in the retina of type 2 diabetic patients","volume":"53","author":"Van Dijk","year":"2012","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.1111\/j.1464-5491.2012.03588.x","article-title":"Retinal nerve fibre layer thinning associated with diabetic peripheral neuropathy","volume":"29","author":"Shahidi","year":"2012","journal-title":"Diabetic Med"},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.1136\/bjo.86.7.725","article-title":"Retinal nerve fibre layer loss in patients with type 1 diabetes mellitus without retinopathy","volume":"86","author":"Lopes De Faria","year":"2002","journal-title":"Br J Ophthalmol"},{"key":"B45","doi-asserted-by":"publisher","first-page":"3","DOI":"10.2174\/157339909787314176","article-title":"Metabolic control and diabetic retinopathy","volume":"5","author":"Rodriguez-Fontal","year":"2009","journal-title":"Curr Diabetes Rev"},{"key":"B46","doi-asserted-by":"publisher","first-page":"792","DOI":"10.3390\/nu14040792","article-title":"Understanding neurodegeneration from a clinical and therapeutic perspective in early diabetic retinopathy","volume":"14","author":"Fragiotta","year":"2022","journal-title":"Nutrients"},{"key":"B47","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1007\/s11892-021-01428-x","article-title":"Retinal neurodegeneration in diabetes: an emerging concept in diabetic retinopathy","volume":"21","author":"Sachdeva","year":"2021","journal-title":"Curr Diabetes Rep"},{"key":"B48","doi-asserted-by":"publisher","DOI":"10.2337\/db21-0853","article-title":"M\u00fcller glial expression of REDD1 is required for retinal neurodegeneration and visual dysfunction in diabetic mice","author":"Miller","year":"2022","journal-title":"Diabetes"},{"key":"B49","doi-asserted-by":"publisher","DOI":"10.3760\/CMA.J.ISSN.0412-4081.2013.06.009","article-title":"Correlation of optic retinal nerve fiber layer thickness and visual function in patients with nonproliferative diabetic retinopathy","volume":"49","author":"Ma","year":"2013","journal-title":"Zhonghua Yan Ke Za Zhi"},{"key":"B50","doi-asserted-by":"publisher","DOI":"10.1167\/iovs.15-18735","article-title":"Early corneal cellular and nerve fiber pathology in young patients with type 1 diabetes mellitus identified using corneal confocal microscopy","volume":"57","author":"Szalai","year":"2016","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"B51","doi-asserted-by":"publisher","DOI":"10.1007\/s00417-016-3548-y","article-title":"Correlation between corneal and retinal neurodegenerative changes and their association with microvascular perfusion in type II diabetes","volume":"97","author":"Hafner","year":"2019","journal-title":"Acta Ophthalmologica"},{"key":"B52","doi-asserted-by":"publisher","DOI":"10.1167\/iovs.14-15924","article-title":"Disorganized retinal lamellar structures in nonperfused areas of diabetic retinopathy","volume":"56","author":"Dodo","year":"2015","journal-title":"Invest Ophthalmol Visual Sci"},{"key":"B53","doi-asserted-by":"publisher","DOI":"10.2337\/diabetes.53.7.1824","article-title":"Direct insulin signaling of neurons reverses diabetic neuropathy","volume":"53","author":"Brussee","year":"2004","journal-title":"Diabetes"},{"key":"B54","doi-asserted-by":"publisher","DOI":"10.1016\/j.nbd.2011.04.012","article-title":"Local insulin and the rapid regrowth of diabetic epidermal axons","volume":"43","author":"Guo","year":"2011","journal-title":"Neurobiol Dis"},{"key":"B55","doi-asserted-by":"publisher","DOI":"10.1111\/jns5.12044","article-title":"Repeated monitoring of corneal nerves by confocal microscopy as an index of peripheral neuropathy in type-1 diabetic rodents and the effects of topical insulin","volume":"18","author":"Chen","year":"2013","journal-title":"J Peripher. Nerv. Syst"},{"key":"B56","doi-asserted-by":"publisher","DOI":"10.2174\/1389450122666210319113136","article-title":"Combination approaches targeting neurodegeneration, oxidative stress and inflammation in the treatment of diabetic retinopathy","volume":"22","author":"Chalke","year":"2021","journal-title":"Curr Drug Targets"},{"key":"B57","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1016\/j.visres.2017.06.014","article-title":"Neurodegeneration in diabetic retinopathy: Potential for novel therapies","volume":"139","author":"Barber","year":"2017","journal-title":"Vision Res"},{"key":"B58","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.coph.2020.08.013","article-title":"Neuropathic damage in the diabetic eye: Clinical implications","volume":"55","author":"Sim\u00f3","year":"2020","journal-title":"Curr Opin Pharmacol"},{"key":"B59","doi-asserted-by":"publisher","DOI":"10.1167\/iovs.17-23678","article-title":"Proteomic analysis of early diabetic retinopathy reveals mediators of neurodegenerative brain diseases","volume":"59","author":"Sundstrom","year":"2018","journal-title":"Invest Ophthalmol Visual Sci"},{"key":"B60","doi-asserted-by":"publisher","DOI":"10.2337\/db17-0382","article-title":"Retinal microperimetry: A new tool for identifying patients with type 2 diabetes at risk for developing Alzheimer disease","volume":"66","author":"Ciudin","year":"2017","journal-title":"Diabetes"}],"updated-by":[{"DOI":"10.3389\/fendo.2026.1809367","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2026,3,6]],"date-time":"2026-03-06T00:00:00Z","timestamp":1772755200000}}],"container-title":["Frontiers in Endocrinology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2022.790255\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,6]],"date-time":"2026-03-06T12:21:32Z","timestamp":1772799692000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2022.790255\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,10,5]]},"references-count":60,"alternative-id":["10.3389\/fendo.2022.790255"],"URL":"https:\/\/doi.org\/10.3389\/fendo.2022.790255","relation":{},"ISSN":["1664-2392"],"issn-type":[{"value":"1664-2392","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,10,5]]},"article-number":"790255"}}